On June 11, 2019, two FDA advisory committees will meet outside Washington DC. One is focused on Drug Safety and Risk Management and the other on Anesthetic and Analgesic Drug Products. Their declared agenda begins as follows: “FDA is seeking public input on the clinical utility and safety concerns associated with the higher range of … Continue reading Joint Meeting of Two FDA Advisory Committees: Are The Blind Again Leading the Blind?
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed